Previous 10 | Next 10 |
Completion of GMP Drug Substances in January for Clinical Trials in H2, 2023 Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the im...
Dr. Joachim-Friedrich Kapp is leading Aditxt’s ADI(TM) immune modulation technology development toward clinical trials The global psoriasis therapeutics market was valued at $22.9 billion in 2021 and is projected to reach $55.8 billion by 2031, growing at a CAGR of 9.3% The primary goa...
Artificial intelligence (AI) is a relatively novel technology with the potential to revolutionize not just the IT industry but a whole slew of sectors. This technology leverages the ability of computer algorithms to analyze enormous data sets and learn from features or patterns in the data. A...
Aditxt (NASDAQ: ADTX) , a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, was featured in recent equity research reports published by H.C. Wainwright & Co. Titled “Personalizing Precision Immunolo...
For quite a while, experts have described concussions and traumatic brain injuries as a “ silent epidemic ” affecting millions across America. Concussions usually occur when an indirect or direct blow to an individual’s head causes their brain to slam against the inside ...
Multiple sclerosis (MS) is a disorder where an individual’s immune system begins attacking the myelin, a protective sheath that protects the nerve fibers. In doing so, the communication signals between the brain and the rest of the body are impacted. An estimated 1 million U.S. ...
More than 700 years ago, a pandemic called the Black Death tore across Europe, taking an estimated 75 million to 200 million lives and reducing the continent’s population by around 30% to 60%. The Black Death was the first wave of a pandemic that lasted almost 500 years and is s...
Organ rejection usually occurs when the immune system of the recipient of a transplanted organ treats the transplanted organ as a foreign object and attacks it. At the moment, patients can only reduce the risk of organ rejection by taking immunosuppressants, which alleviate symptoms of re...
Food allergies have become more common these past few years in both adults as well as children. Allergies are defined as the immune system’s overreaction to an antibody known as immunoglobulin E. This protein is usually produced by the immune system to help detect and attack invader...
Scientists from University of Texas Southwestern Medical Center, Dallas, and Andover, Massachusetts and TransMedics have discovered that there are transplanted livers that have a cumulative age exceeding one hundred years. The team of scientists studied those livers in order to find out wh...
News, Short Squeeze, Breakout and More Instantly...
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
ADiTx Therapeutics Inc. Website:
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Women’s health innovator Evofem Biosciences, Inc. (“Evofem” or “the Company”) (OTCQB: EVFM) today announced that Saundra Pelletier, Chief Executive Officer and Amy Raskopf, Chief Business Development Officer...
Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious disease and biodefense markets. Subject to the renewal of certain legislation, two programs are potentially eligible for FDA Priority Review Vouchers Aditxt, Inc. (...
Evofem Biosciences Inc. (OTCQB: EVFM) , a company commercializing innovative products to address unmet needs in women's sexual and reproductive health, has signed a license and supply agreement for the Middle East rights to Phexxi(R), Evofem's FDA-approved, hormone-free contra...